TABLE 2.
Compound plate codeb | MMV identifierc | Mean % mortality for adultsd | SD for % mortality for adultsd |
---|---|---|---|
TCBZ | NA | 100e | 0 |
PAG6 | MMV063404 | 67 | 33.3 |
PBF4 | MMV003270 | 67 | 0 |
PBF11 | MMV085210 | 0 | 0 |
PBH10 | MMV676380 | 78 | 19.2 |
PCC5 | MMV687730 | 11 | 19.2 |
PCC6 | MMV687251 | 33 | 33.3 |
PCD11 | MMV1030799 | 67 | 33.3 |
PCE8 | MMV690102 | 56 | 19.2 |
PCE11 | MMV1029203 | 78 | 19.2 |
PCF2 | MMV676053 | 0 | 0 |
PCF3 | MMV688179 | 22 | 19.2 |
PCF4 | MMV023969 | 33 | 33.3 |
PCF11 | MMV688921 | 67 | 33.3 |
Compounds in italics were selected for evaluation of the IC50 for adult worms and for use in the cytotoxicity assay with cell lines. NA, not applicable.
Coordinates used to identify the compounds in each plate. TCBZ, triclabendazole.
Identification codes assigned by the Medicines for Malaria Venture (MMV).
Measured at 48 h after drug exposure for adult worms. Results are means and standard deviations from triplicate experiments at a concentration of 33 μM.
Mean and standard deviation from 6 individual experiments performed in 3 plates.